C. I. Li

635 citations
7 papers · 439 indexed · h-index 6

C. I. Li

7 papers receiving 430 citations

Peers

C. I. Li
Comparison fields: 5 of 53
  • Cancer Research 176
  • Oncology 305
  • Otorhinolaryngology 41
  • Drug Discovery 1
  • Genetics 113
Replace Oscar Mang with:
Oscar Mang China
Gabriel Farante Italy
Sabine Pöstlberger Austria
Mustafa Tükenmez Türkiye
Valérie Cristina Switzerland
Christina A. Dilaveri United States
P Vodvářka Czechia
Chan Seok Yoon South Korea
İbrahim Petekkaya Türkiye
Hyma Schubert Switzerland
C. I. Li relative to Oscar Mang China Oscar Mang's profile →
Citations per field
00.5×1.5×2.2×
Oscar Mang · 1×
Citations per year

Countries citing papers authored by C. I. Li

Since Specialization
Citations

This map shows the geographic impact of C. I. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. I. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. I. Li more than expected).

Fields of papers citing papers by C. I. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. I. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. I. Li. The network helps show where C. I. Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. I. Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. I. Li Line = papers co-authored together C. I. Li links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer Jennifer C. LivaudaisDawn L. HershmanLaurel HabelLawrence Kushi • Scarlett Lin GomezChristopher I. LiAlfred I. NeugutLouis Fehrenbacher • Beti ThompsonGloria D. Coronado
20121
2 201120
3 2011165
4 201017
5 201097
6 200787
7 200652

About C. I. Li

C. I. Li is a scholar working on Family Practice, Otorhinolaryngology and Cancer Research, having authored 7 papers that have together received 439 indexed citations. Recurring topics across this work include Cancer Risks and Factors (3 papers), BRCA gene mutations in cancer (2 papers), Breast Cancer Treatment Studies (2 papers), Bone health and treatments (1 paper), Single-cell and spatial transcriptomics (1 paper), Estrogen and related hormone effects (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Cancer Research (176 citations), Oncology (305 citations) and Otorhinolaryngology (41 citations). C. I. Li has collaborated with scholars based in United States, South Africa and Norway. Frequent co-authors include Rowan T. Chlebowski, Dorothy S. Lane, Ross L. Prentice, Jean Wactawski‐Wende, Amanda I. Phipps, Lucile L. Adams‐Campbell, Marcia L. Stefanick, Geoffrey C. Kabat, T.L. Vaughan and Eng‐Yen Huang. Their work appears in journals such as JNCI Journal of the National Cancer Institute, American Journal of Epidemiology and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026